Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online February 2, 2006
Stem Cells Vol. 24 No. 6 June 2006, pp. 1458 -1466
doi:10.1634/stemcells.2005-0413; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0413v1
24/6/1458    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dihné, M.
Right arrow Articles by Schachner, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dihné, M.
Right arrow Articles by Schachner, M.

EMBRYONIC STEM CELLS

Embryonic Stem Cell-Derived Neuronally Committed Precursor Cells with Reduced Teratoma Formation After Transplantation into the Lesioned Adult Mouse Brain

Marcel Dihnéa,b, Christian Bernreuthera, Christian Hagelc, Kai O. Weschea, Melitta Schachnera

a Zentrum für Molekulare Neurobiologie, Universität Hamburg, Hamburg, Germany;
b Department of Neurology, Heinrich-Heine-University, Duesseldorf, Germany;
c Institute of Neuropathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Key Words. Cellular proliferation • Stem cell transplantation • Neural differentiation • Embryonic stem cells • Committed progenitors • Cellular therapy

Correspondence: Marcel Dihné, M.D., University of Düsseldorf – Neurology, Moorenstrasse 5, 40225 Düsseldorf, Germany. Telephone: +00491752741681; Fax: _492118 1184 69; e-mail: marcel.dihne{at}uni-duesseldorf.de

Received August 26, 2005; accepted for publication January 25, 2006.

The therapeutic potential of embryonic stem (ES) cells in neurodegenerative disorders has been widely recognized, and methods are being developed to optimize culture conditions for enriching the cells of interest and to improve graft stability and safety after transplantation. Whereas teratoma formation rarely occurs in xenogeneic transplantation paradigms of ES cell-derived neural progeny, more than 70% of mice that received murine ES cell-derived neural precursor cells develop teratomas, thus posing a major safety problem for allogeneic and syngeneic transplantation paradigms. Here we introduce a new differentiation protocol based on the generation of substrate-adherent ES cell-derived neural aggregates (SENAs) that consist predominantly of neuronally committed precursor cells. Purified SENAs that were differentiated into immature but postmitotic neurons did not form tumors up to four months after syngeneic transplantation into the acutely degenerated striatum and showed robust survival.




This article has been cited by other articles:


Home page
BrainHome page
C. Buhnemann, A. Scholz, C. Bernreuther, C. Y. Malik, H. Braun, M. Schachner, K. G. Reymann, and M. Dihne
Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats
Brain, December 1, 2006; 129(12): 3238 - 3248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.